vorinostat has been researched along with Uterine Neoplasms in 2 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Uterine Neoplasms: Tumors or cancer of the UTERUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Prospective study comparing uterine leiomyoma (UL) vs." | 1.72 | Histone deacetylase inhibition by suberoylanilide hydroxamic acid: a therapeutic approach to treat human uterine leiomyoma. ( Carbajo-García, MC; Corachán, A; Faus, A; Ferrero, H; García-Alcázar, Z; Monleón, J; Pellicer, A; Trelis, A, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carbajo-García, MC | 1 |
| García-Alcázar, Z | 1 |
| Corachán, A | 1 |
| Monleón, J | 1 |
| Trelis, A | 1 |
| Faus, A | 1 |
| Pellicer, A | 1 |
| Ferrero, H | 1 |
| Fröhlich, LF | 1 |
| Mrakovcic, M | 1 |
| Smole, C | 1 |
| Lahiri, P | 1 |
| Zatloukal, K | 1 |
2 other studies available for vorinostat and Uterine Neoplasms
| Article | Year |
|---|---|
Histone deacetylase inhibition by suberoylanilide hydroxamic acid: a therapeutic approach to treat human uterine leiomyoma.
Topics: Adult; Antineoplastic Agents; Cell Cycle; Cell Proliferation; Extracellular Matrix; Female; Gene Exp | 2022 |
Epigenetic silencing of apoptosis-inducing gene expression can be efficiently overcome by combined SAHA and TRAIL treatment in uterine sarcoma cells.
Topics: Apoptosis; Caspase 3; Caspase 8; Cell Line, Tumor; DNA Methylation; Drug Resistance, Neoplasm; Drug | 2014 |